A fungal virus for improving the toxicity of Beauveria bassiana and a method for transmitting the virus

By extracting and identifying multimeric double-stranded RNA virus from the strain BbOFJY of the white coccidioidae, and using insect body to transmit poison, the shortcomings of the virulence enhancement and poison transmission methods of the prior art are solved. , achieving the effect of improving the virulence of coccidioidae and reducing production costs.

CN114480300BActive Publication Date: 2024-12-06JILIN ACAD OF AGRI SCI
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202110718357.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-06-28
Publication Date
2024-12-06
Estimated Expiration
2041-06-28

AI Technical Summary

Technical Problem

The existing double-stranded RNA virus of Coccidioidae on the virulence enhancement of the host Coccidioidae has not been reported, and the toxic transmission method mainly relies on culture medium to culture, and lacks other effective transmission pathways.

Method used

A multimeric double-stranded RNA fungal virus was developed to use insect bodies to transmit poison. Specifically, nucleotide sequences were extracted and identified from the strain BbOFJY of the white coccidioidae strain BbOFJY isolated in the corn field of Jingyu County, Jilin Province. Combined with specific poison transmission methods, the virility of C. leukobassobacteria was successfully increased.

Benefits of technology

This method creates a new strain of high virility, which increases the virility of the white coccidioidae to pests, reduces the cost of production and control, and provides a new transmission pathway through insect bodies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FDA0005069429690000011
    Figure FDA0005069429690000011
  • Figure FDA0005069429690000012
    Figure FDA0005069429690000012
  • Figure GDA0005123649450000061
    Figure GDA0005123649450000061
Patent Text Reader

Abstract

The present invention provides a double-stranded RNA fungal virus of the family Polyviridae for improving the virulence of Beauveria bassiana, comprising the nucleotide sequences shown in SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6; and use of the double-stranded RNA fungal virus of the family Polyviridae for improving the virulence of Beauveria bassiana. The present invention also provides a Beauveria bassiana strain containing the double-stranded RNA fungal virus of the family Polyviridae.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a novel polyviridae double-stranded RNA fungal virus capable of improving the insecticidal toxicity of Beauveria bassiana, a Beauveria bassiana strain containing the virus and application thereof. Background Art

[0002] Beauveria bassiana has a wide host range and is a biological control agent for crop pests. Beauveria bassiana is widely used in the biological control of crop diseases and insect pests. It mainly relies on conidia to achieve its endophytic properties and directly act on target pests. Studies have shown that the virulence of Beauveria bassiana is closely related to the mycelial growth rate, growth environment, culture medium nutrition, etc. Recent studies have shown that fungal viruses can affect the virulence of Beauveria bassiana.

[0003] Studies have shown that more than one-fifth of Beauveria bassiana isolates from around the world contain double-stranded RNA viruses, mainly including the three families of Totiviridae, Partitiviridae, and Polymycoviridae, as well as the unclassified Narnaviridae with the smallest genome. At present, a small number of double-stranded RNA viruses reported in Beauveria bassiana belong to Totiviridae, and some belong to Partitiviridae containing 2-4 double-stranded RNAs, while Polymycoviridae is composed of more than 4 double-stranded RNAs, but no RNA-deficient viruses have been found.

[0004] In the study of the effect of double-stranded RNA viruses on the host Beauveria bassiana, some studies have shown that the colony growth rate and biomass of Beauveria bassiana strains containing Polymycoviridae viruses are lower than those without viruses, and many specific viruses lead to a decrease in the growth rate and biomass of the host Beauveria bassiana; in the study of the insecticidal activity of endogenous viruses on Beauveria bassiana, it has been reported that Partitiviridae viruses reduce the insecticidal activity of Beauveria bassiana, and the effect of polymer viruses on the virulence of Beauveria bassiana has not been reported. At the same time, the main method of fungal virus transmission is culture medium confrontation, and no other transmission methods have been found. Summary of the invention

[0005] The purpose of the present invention is to provide a fungal endogenous polymeric double-stranded RNA virus that is positively correlated with the toxicity and growth rate, spore germination rate, bacterial body dry weight and blastospore concentration of Beauveria bassiana to pests, and a method for transmitting the virus using insect bodies, in order to improve the toxicity of Beauveria bassiana in the process of controlling pests.

[0006] The virus is endogenous to the Beauveria bassiana strain BbOFJY isolated from the larvae of the Asian corn borer in the corn field in Jingyu County, Jilin Province. The strain was deposited in the General Microbiological Center (CGMCC) of the China Microbiological Culture Collection Administration on March 18, 2021, and the strain deposit number is CGMCC No.22429.

[0007] In one embodiment, the present invention provides a double-stranded RNA fungal virus of the family Polyviridae, comprising the nucleotide sequences shown in SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 and SEQ ID NO:6.

[0008] In one embodiment, the present invention provides a double-stranded RNA fungal virus of the family Polyviridae, which consists of the nucleotide sequences shown in SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 and SEQ ID NO:6.

[0009] In one embodiment, the present invention provides a method for improving the insecticidal toxicity of Beauveria bassiana using a double-stranded RNA fungal virus of the family Polyviridae.

[0010] In one embodiment, the present invention provides a method for controlling plant pests, comprising using insect bodies to infect Beauveria bassiana with the double-stranded RNA fungal virus of the Polyviridae family.

[0011] By transferring the above-mentioned virus to Beauveria bassiana using a new method of virus transmission, a new highly toxic strain was successfully created, thereby increasing the toxicity of Beauveria bassiana to pests and reducing production and control costs.

[0012] In another aspect, the present invention provides a Beauveria bassiana strain containing the polymeric double-stranded RNA fungal virus.

[0013] In one embodiment, the deposit number of the strain is CGMCC No.22429.

[0014] Unless otherwise defined, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. In the event of a conflict, the present application specification shall prevail. Preferred methods and materials are described below, but methods and materials similar or equivalent to those described herein can be used to implement or test the present invention. The materials, methods and examples disclosed herein are illustrative only and are not intended to be limiting. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1Agarose gel electrophoresis diagram of dsRNA extraction results.

[0016] Figure 2 This is the structure diagram of the BbPmV-4 virus genome.

[0017] Figure 3 It is the result of multiple sequence alignment of the 5' and 3' regions of the viral genome.

[0018] Figure 4 The images are the detection of dsRNA (A) and RT-PCR (B) of the virus-free strain.

[0019] Figure 5 The figure shows the effect of the virus on the colony morphology (A) and growth rate (B) of Beauveria bassiana on PDA medium.

[0020] Figure 6 Effects of the virus on the colony morphology (A) and growth rate (B) of Beauveria bassiana on Czapek medium.

[0021] Figure 7 Effects of viruses on the spore production of Beauveria bassiana (A, B), 12-hour spore germination rate (C), and 16-hour spore germination rate (D).

[0022] Figure 8 Effects of viruses on the dry weight of Beauveria bassiana.

[0023] Fig. 9 Effects of viruses on the spore production of Beauveria bassiana.

[0024] Fig.10 Extraction and detection of double-stranded RNA of virus-transmitting strains

[0025] Fig.11 Virus RT-PCR detection of infectious strains

[0026] Fig.12 LT50 determination of toxicity to pests DETAILED DESCRIPTION

[0027] Example 1 Isolation and Identification of Double-stranded RNA Genes from Beauveria bassiana

[0028] 1.1 Isolation of double-stranded RNA from Beauveria bassiana strains

[0029] 1) Grind the dried mycelium into powder in a sterile mortar;

[0030] 2) Add 2×GPS buffer: 500μL; Trizol: 500μL; Chloroform: 500μL; 10% SDS: 150μL to every 0.2g sample. Mix well and shake at room temperature for 10 minutes;

[0031] 3) Centrifuge at 12000 r / min, 4°C for 10 min, and transfer the supernatant to a new sterile 2 mL centrifuge tube;

[0032] 4) Add 0.05 g of cellulose powder to the solution, and add anhydrous ethanol at a ratio of 180 μL of anhydrous ethanol per 1000 μL of solution;

[0033] 5) Place the mixture in an ice bath for 0.5 h to allow the cellulose powder to fully absorb the dsRNA, centrifuge at 12,000 rpm, 4°C for 2 min, and discard the supernatant;

[0034] 6) Add 600 μL of elution buffer, mix thoroughly and place on ice for 1 min, centrifuge at 12000 rpm, 4°C for 2 min, and discard the supernatant;

[0035] 7) Repeat step 6;

[0036] 8) Add 650 μL of 1× STE solution, shake for 5 min, and place on ice for 3 min;

[0037] 9) Centrifuge at 12000 r / min, 4°C for 5 min, transfer the supernatant to a 1.5 mL sterile centrifuge tube and add an equal volume of isopropanol, gently invert to mix, and let stand at -20°C for more than 1 hour;

[0038] 10) Centrifuge at 4°C, 12000 rpm for 10 min and discard the supernatant;

[0039] 11) Add 600 μL of 75% ethanol to wash the precipitate, centrifuge at 4°C, 12000 rpm for 2 min, and discard the supernatant;

[0040] 12) Repeat step 11;

[0041] 13) Centrifuge at 4°C, 12000 rpm for 1 min and remove the residual liquid with a pipette;

[0042] 14) Dry under vacuum at 37°C for 3 min, and add DEPC water to dissolve dsRNA.

[0043] 1.2 Viral genome amplification

[0044] 127 μg of sample was sent to Novogene Biotechnology Co., Ltd. for double-end sequencing of transcriptome on the Hiseq-PE150 platform, with a sequencing length of 150 bp in each direction. After sequencing, Spades (V3.13.1) software was used to analyze the transcriptome data (Antipov et al., 2020), and the sequences were spliced ​​to obtain partial sequences of 6 dsRNAs. The spliced ​​sequences were aligned by BLASTp, and partial sequences of dsRNA1, dsRNA2, dsRNA3, and dsRNA4 were obtained. The annotation results did not match the sequence information about dsRNA5 and dsRNA6. The sequences of dsRNA1, dsRNA2, dsRNA3, and dsRNA4 need to be end cloned, and the sequences of dsRNA5 and dsRNA6 need to be randomly cloned.

[0045] Add adapter to the reaction. Take 12μL of dsRNA sample, add 1μL of PC3-T7 loop (30pmol / μL) adapter or RACE-oligo (30pmol / μL) adapter; 2μL of DMSO solution, heat at 90℃ metal bath for 5min, immediately put in ice bath for 5min, add the following drugs in sequence: RNase inhibitor: 1μL; 10×T4 RNA ligase buffer: 5μL; 50% PEG6000: 25μL; BSA: 3μL; T4 RNA ligase: 1μL, total system 50μL, place in ice water mixture to keep the temperature at 4-16℃, and react for 24h.

[0046] Take the product of the previous step, add DEPC water to make the total system reach 800μL, add 300μL chloroform for extraction; centrifuge at 4℃, 12000r / min for 10min, aspirate 700μL supernatant, add 5μL nucleic acid precipitation agent and mix by inversion, add 0.1 times volume of 3M NaAC with pH = 5.2; add an equal volume of isopropanol, precipitate at -20℃ for more than 30min; centrifuge at 4℃, 12000r / min for 10min, discard the supernatant; add 600μL 75% ethanol to wash the precipitate, centrifuge for 2min, discard the supernatant; dry at room temperature, and dissolve the precipitate with DEPC water.

[0047] Take the purified dsRNA for reverse transcription. If connecting to RACE-oligo adapter, add reverse transcription primer RACE1: 3μL; 11.5μL of purified dsRNA solution; 2μL of DMSO solution, mix well and treat at 95℃ for 3min, and immediately ice bath for 5min. There is a hairpin structure when connecting to PC3-T7 loop adapter, so no reverse transcription primer is needed. Add 14.5μL of purified dsRNA solution; 2μL of DMSO solution, mix well and treat at 95℃ for 3min, and immediately ice bath for 5min. Add the following drugs in sequence: 5×Reverse Transcriptase M-MLV Buffer: 5μL; dNTP (10mM): 2μL; RNA inhibitor (40U / μL): 0.5μL; Reverse TranscriptaseM-MLV (200U / μL): 1μL, total system 25μL. Mix gently, set the metal bath to react at 30°C for 10 min, 42°C for 1 h, 70°C for 15 min, and store at 4°C. Perform nested PCR using the following system.

[0048] PCR amplification system

[0049]

[0050] The PCR negative control cDNA was ddH2O, and the PCR program was set as 95℃ pre-denaturation reaction for 3min; 94℃ denaturation reaction for 30s, 55℃ annealing reaction for 30s, 72℃ extension reaction for 50s, 30-35 cycles; 72℃ extension reaction for 5min, and storage at 16℃. After electrophoresis, the nested PCR product was recovered using the Omega DNA gel recovery kit, and the recovered PCR products were cloned and sequenced. First, 4.5μL of gel recovery product, 0.5μL of pMD18-T Vector, and 5μL of Solution I were mixed evenly and placed in a 16℃ metal bath for reaction for more than 1h (the PCR product of long fragments can extend the connection time and can be connected for 4-12h overnight). Take out the competent cells from the -80℃ refrigerator and place them on ice, add 10μL of connection solution to 50μL of competent cells, and ice bath for 30min. Heat shock in a 42℃ water bath for 60s, immediately ice bath for 3min, add 400μL LB liquid culture medium, and culture at 37℃ shaker at 200r / min for 30min. Pipette 200μL bacterial solution and apply it to LB solid culture medium containing 0.1mg / mL Amp, and culture at 37℃ inverted for 12h. Pick single colonies with a sterile toothpick, pick 8 from each dish, and put them into LB liquid culture medium containing 0.1mg / mL Amp, and culture at 37℃ shaker at 200r / min for 6h. When the bacterial solution is turbid, perform bacterial solution PCR detection, use M13F-47 and M13R-48 and specific primers for detection, and send bacterial solution samples containing a single target fragment to Wuhan Jinkairui Bioengineering Co., Ltd. for sequencing.

[0051] Fragments dsRNA5 and dsRNA6 were randomly cloned. The extracted RNA crude extract was treated with DNase I and SI nuclease to remove DNA and single-stranded RNA (ssRNA) in the sample. The RNA crude extract: 26.5μL, 10×DNaseI buffer: 3μL, 10×SI buffer: 3μL, DNaseI (5U / μL): 0.4μL, SI (180U / μL): 0.1μL were added to the enzymatic system in sequence, and the reaction was placed at 25℃ for 1h, 65℃ metal bath for 5min, and stored at 4℃ or -20℃. The optimal reaction temperature of SI nuclease is 23℃, and the optimal reaction temperature of DNaseI is 37℃. It can be placed at room temperature for simultaneous reaction. After the electrophoresis bands of dsRNA5 and dsRNA6 were recovered and purified using the aforementioned method, reverse transcription was performed using the purified dsRNA as a template and RACE3RT (30pm / μL) as a reverse transcription primer. The reverse transcription system is as follows: the dsRNA content needs to be 50-100ng, add 1μL of RACE3RT (30pm / μL), add 2μL of DMSO, add DEPC water to 15μL, mix well, treat at 95℃ for 3min, and immediately ice bath for 5min. Perform the reverse transcription reaction according to the above method. Add 2.5μL of 1M NaOH to the reverse transcription product, react at 65℃ for 1h, cool at room temperature, add 2.5μL of 1M Tris-HCl (pH=7.5-8.0), 2.5μL of 1M HCl, renature at 65-68℃ for 1h, and the product can be directly used as cDNA for PCR reaction.

[0052] Take the above cDNA for fill-in and PCR amplification reaction. The PCR amplification system is the same as 2.2.4.4, and the primer is RACE3 (30pm / μL). The PCR program is set as: 95℃ denaturation for 5min, 72℃ extension for 10min, to complete the fill-in reaction. 95℃ pre-denaturation reaction for 3min; 94℃ denaturation reaction for 30s, 55℃ annealing reaction for 30s, 72℃ extension reaction for 1min, 30-35 cycles; 72℃ extension reaction for 5min, 16℃ storage, to complete the PCR amplification reaction. 1% agarose gel electrophoresis was used to detect the PCR product and it was found that the amplified band was continuous. The part with a size close to the target fragment, that is, 250-1000bp, was selected for gel excision and recovery. The PCR product was recovered using the Omega DNA gel recovery kit and connected to the vector for sequencing.

[0053] 1.3. Viral genome sequence alignment and identification

[0054] Chromas (2.6.6.0) was used to analyze the sequencing results, and DNAMAN (version 9) was used for sequence splicing. Specific primers were designed for dsRNA1, dsRNA2, dsRNA3, dsRNA4, dsRNA5 and dsRNA6 for PCR amplification and detection of the full-length sequence, and the products were recovered and connected to the vector for sequencing. The ORF (Open-Reading Frame) of dsRNAs was predicted by NCBI's ORF Finder (https: / / www.ncbi.nlm.nih.gov / orffinder / ). Sequence similarity search was performed using BLASTP (http: / / www.ncbi.nlm.nih.gov). The conserved domains of dsRNAs were predicted by the NCBI Conserved Domain Database (CDD). A phylogenetic tree was constructed using the ML method using MEGAX, and 1000 bootstrap analyses were performed.

[0055] Results

[0056] The electropherogram of dsRNA extraction results can be found in Figure 1 After the above sequencing, it was found that the full-length genome sequence of the virus includes the following 6 parts: dsRNA1, dsRNA2, dsRNA3, dsRNA4, dsRNA5 and, whose nucleotide sequences are shown in SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 and SEQ ID NO:6, respectively. These sequences are described in more detail below.

[0057] After terminal sequence cloning and random cloning, the full lengths of dsRNA1, dsRNA2, dsRNA3, dsRNA4, dsRNA5 and dsRNA6 were 2427bp, 2280bp, 2015bp, 1106bp, 867bp and 794bp, respectively. Sequence homology analysis revealed that the dsRNA1 sequence of the virus had the highest similarity of 72.16% with the RdRp sequence of BbPmV-3 reported in Beauveria bassiana, followed by a higher similarity of 71.45% with the RdRp sequence of BbPmV-2. Therefore, it was preliminarily determined to be a new polymycovirus and named Beauveria bassiana polymycovirus 4 (BbPmV-4). The genome of BbPmV-4 consists of 6 fragments, and its nucleotide sequence accession numbers in the GenBank database are MW385785-MW385790. The genome structure of BbPmV-4 is shown in the figure below. Figure 2As shown, each fragment encodes an open reading frame, and the 5′ and 3′ ends of the six fragments are highly conserved ( Figure 3 ), which has a high similarity with the terminal conserved sequence of BbPmV-3, and the conserved sequence at the 5′ end (GAANUNAAGNGUUNUUCUNCNCAAG) and the conserved sequence at the 3′ end (UUU) are the same. It was named BbPmV-4.

[0058] ORF1 encoded by dsRNA1 starts at 27nt and ends at 2333nt, encoding 768aa. Using BLASTp to search the database, it was found that the amino acid sequence of BbPmV-4 had the highest similarity of 79.43% with BbPmV-2 (GenBank accession number: CUS18599.1; query coverage = 100%; E-value = 0), encoding RdRp. Searching and comparing in the conservative domain database, there was an RT-like superfamily conservative domain (GenBank accession number: cl02808; E-value = 4.44e-04).

[0059] ORF2 encoded by dsRNA2 starts at 71nt and ends at 2170nt, encoding 699aa. Using BLASTp to search the database, it was found that the amino acid sequence of BbPmV-4 had a maximum similarity of 82.35% with BbPmV-3 (GenBank accession number: CAD7829824.1; query coverage = 91%; E-value = 0), encoding a putative scaffold protein. Searching and comparing in the conserved domain database showed that there was no conserved domain.

[0060] ORF3 encoded by dsRNA3 starts at 52nt and ends at 1905nt, encoding 617aa. Using BLASTp to search the database, it was found that the amino acid sequence of BbPmV-4 has the highest similarity with BbPmV-3, which is 74.39% (GenBank accession number: CAD7829825.1; query coverage = 91%; E-value = 0), encoding a methyltransferase. Searching and comparing in the conserved domain database, there is an AdoMtr-MTases superfamily conserved domain (GenBank accession number: cd02440; E-value = 2.02e-06).

[0061] ORF4 encoded by dsRNA4 starts at 111nt and ends at 908nt, encoding 265aa. Using BLASTp to search the database, it was found that the amino acid sequence of BbPmV-4 had a maximum similarity of 80.15% with BbPmV-3 (GenBank accession number: CAD7829826.1; query coverage = 71%; E-value = 9e-152), encoding PASrp. Searching and comparing in the conserved domain database showed that there was no conserved domain.

[0062] ORF5 encoded by dsRNA5 starts at 105nt and ends at 713nt, encoding 202aa. Using BLASTp to search the database, it was found that the amino acid sequence of BbPmV-4 had a maximum similarity of 61.76% with BbPmV-3 (GenBank accession number: CAD7829828.1; query coverage = 69%; E-value = 1e-33), encoding an unknown protein. Searching and comparing in the conserved domain database showed that there was no conserved domain.

[0063] ORF6 encoded by dsRNA6 starts at 111nt and ends at 596nt, encoding 161aa. Using BLASTp to search the database, it was found that the amino acid sequence of BbPmV-4 had a maximum similarity of 78.95% with BbPmV-3 (GenBank accession number: CAD7829826.1; query coverage = 50%; E-value = 2e-70), encoding PASrp. Searching and comparing in the conserved domain database showed that there was no conserved domain.

[0064] Example 2 Effect of virus BbPmV-4 detoxification on the biological characteristics of Beauveria bassiana

[0065] 2.1 Obtaining and analyzing virus-free strains

[0066] Single spores of Beauveria bassiana BbOFJY were isolated and inoculated on PDA plates and placed in a constant temperature incubator at 26°C for dark culture for 5 days. The tips of the hyphae were cut and inoculated on new PDA plates for culture. The tips of the hyphae were cut and subcultured for 5 generations continuously to detect whether the isolated strains were detoxified. The dsRNA of the strains was extracted, and DNase I and S1 nucleases were treated. The strains were detected by 1% agarose gel electrophoresis. The original strains were used as positive controls, and RT-PCR was used to detect whether the strains were detoxified, thereby obtaining the detoxified strain BbOFJYF. After extraction and screening, the hyphae of the strains were verified for dsRNA extraction, and preliminary screening was performed to obtain dsRNA-free strains. Total RNA was extracted for the preliminary screening strains, and N6 random primers (10 pm / μL) were used as reverse transcription primers. The dsRNA content needs to be 50-100ng, add 1μL of N6 (10pm / μL), add 2μL of DMSO, add DEPC water to 15μL, mix well, treat at 95℃ for 3min, and immediately ice bath for 5min. Using the obtained cDNA as a template, use primers to perform PCR amplification for the virus-specific sequence. A positive RT-PCR indicates that the virus-free strain has been successfully obtained, marked as BbOFJYF.

[0067] BbPmV-4 detection primers

[0068]

[0069] The PCR program is as follows:

[0070]

[0071] 2.2 Strain growth rate and colony morphology characteristics

[0072] BbOFJY and BbOFJYF strains were inoculated into PDA medium and placed in a constant temperature incubator at 26°C for dark culture for 10 days. The spore suspension was prepared with sterile water, mixed thoroughly and counted with a hemocytometer, and diluted to a concentration of 5×10 4 / mL, add 2μL spore suspension, that is, n=100 spores, to the center of the plate, 10 replicates per group, and inoculate in Czapek medium and PDA medium at the same time, with 25mL medium per plate. Place in a 26℃ constant temperature incubator for culture, measure the colony diameter by the cross method from the beginning of colony growth and record for 15 days, and observe the colony color, matrix color, and morphological characteristics of Beauveria bassiana at the same time. The experiment was repeated twice. IBM SPSS Statistics 26 software was used to perform variance homogeneity test and descriptive statistics on the data, and Duncan's method was used for multiple comparisons and significance analysis.

[0073] 2.3 Determination of spore production and spore germination rate

[0074] BbOFJY and BbOFJYF strains were inoculated into PDA medium, with each plate containing 25 ml of medium. 2 μL of 5×10 4 Spore suspension of n = 100 spores / ml was placed in the center of the PDA medium and cultured in a 26°C constant temperature incubator for 15 days. Each strain was repeated 3 times. All spores on the plate were scraped off, 10 mL of 0.05% Tween-80 was added and mixed thoroughly. The spores were counted under a microscope using a hemocytometer to calculate the average spore production per dish of the strain.

[0075] Take the BbOFJY and BbOFJYF strains cultured for 15 days, wash the spores with sterile water, and add 1×10 7 spores were added to 20 mL SDY liquid medium and cultured at 26°C and 200 r / min for 12 h and 16 h, with 5 replicates per group. An appropriate amount of bacterial liquid was dropped on the center of the slide, placed under a microscope, and the spore germination was observed and recorded. When the length of the germ tube was greater than or equal to the spore diameter, it was considered to have germinated. Each treatment had no less than 100 spores when observed under a microscope, and the microscopic examination was repeated 3 times.

[0076] 2.4 Determination of dry weight accumulation of bacteria

[0077] Take the BbOFJY and BbOFJYF strains cultured for 15 days, wash the spores with sterile water, and add 2×10 7 spores were cultured at 26°C and 200 r / min for 1, 2, 3, 4, and 5 days, and then the culture medium was filtered out with double-layer filter paper. The filter paper and mycelium were dried in an oven at 80°C, weighed and counted, with 3 replicates for each treatment.

[0078] 2.5 Observation of blastospores

[0079] Take the BbOFJY and BbOFJYF strains cultured for 15 days, wash the spores with sterile water, and add 5×10 7 Spores were cultured at 26°C and 200 r / min. The morphology of spores was recorded at 24h, 36h, 48h, 60h, 72h, 84h, 96h, 108h and 120h. Each treatment was repeated 3 times, and the spore concentration was recorded.

[0080] 2.6 Results

[0081] 2.6.1 Verification of virus-free strains

[0082] The offspring strains isolated from the single spore were subcultured with the mycelial tips for 5 generations and then dsRNA was extracted. The results showed that one of the strains did not contain dsRNA bands. It showed nucleic acid before DNase 1 and S1 nuclease treatment, but showed an empty lane after DNase 1 and S1 nuclease treatment ( Figure 4 ), while the original strain showed dsRNA bands after and without DNase 1 and S1 nuclease treatment. In order to further prove that the strain has been detoxified, the strain was tested by RT-PCR, and two pairs of primers were used for detection and analysis. The results showed that the BbOFJY strain amplified target bands of 333bp and 712bp respectively, and the BbOFJYF strain was negative for both pairs of primers ( Figure 4 -B). Therefore, the strain BbOFJYF was determined to be a virus-free strain for subsequent experiments.

[0083] 2.6.2 Observation of strain growth rate and colony morphology

[0084] The original strain BbOFJY and the virus-free strain BbOFJYF were inoculated on PDA medium and placed in a constant temperature incubator at 26°C for dark culture. After 9 days of culture, the colony morphology showed significant differences: the original strain BbOFJY showed raised concentric rings and the colonies were loose and thin, with radial and regular edges; while the virus-free strain BbOFJYF colonies were densely villi-like, thick and uneven, with irregular edges ( Figure 5 ), the growth diameter of the colonies showed differences on the 3rd day, and the data analysis between the groups showed that the differences were extremely significant. Then on the 6th to 15th day, the colony diameter of strain BbOFJY was significantly higher than that of strain BbOFJYF, and the intra-group data had good repeatability and a small standard error. The presence of BbPmV-4 can promote the growth of strain BbOFJY.

[0085] The original strain BbOFJY and the virus-free strain BbOFJYF were inoculated on Czapek medium and placed in a constant temperature incubator at 26°C for dark culture. After 12 days of culture, the colony morphology showed differences: the colony edge of the original strain BbOFJY was radial, relatively regular, and had few protrusions; the colony edge of the virus-free strain BbOFJYF was irregular and uneven ( Figure 6 ). Both strains grew slowly on Czapek's medium, and the overall growth rate was lower than that on PDA plates. Czapek's medium was poorer in nutrients than PDA medium. The growth rates of the original strain BbOFJY and the virus-free strain BbOFJYF on Czapek's medium were significantly different. The presence of BbPmV-4 could promote the growth of strain BbOFJY.

[0086] 2.6.3 Determination of spore production and spore germination rate

[0087] The BbOFJY and BbOFJYF strains inoculated in PDA medium were placed in a 26°C constant temperature incubator for 15 days. Figure 7 A is the plate after the strain was scraped. The concentric rings and regular colony edges of strain BbOFJY can still be seen, and the irregular colony edges of strain BbOFJY can still be seen. Add 0.05% Tween-80 to 10 ml and mix thoroughly. The average spore production per plate of strain BbOFJY is 5.08×10 7 The average spore production of strain BbOFJYF per dish was 7.06×10 7 The difference is quite significant ( Figure 7 B). The colony morphology of strain BbOFJY was relatively loose, but the spore production was significantly lower than that of strain BbOFJYF. The fresh weight of the strains was analyzed and it was found that the fresh weight of mycelium of strain BbOFJYF was slightly higher than that of strain BbOFJY, but the difference was not significant, which may be related to the fact that the colony of strain BbOFJYF was denser and fluffy.

[0088] Take the BbOFJY and BbOFJYF strains cultured for 15 days, wash the spores with sterile water, and add 1×10 7 The spores were added to 20 mL SDY medium and cultured at 26°C and 200 r / min for 12 h and 16 h respectively. The spore germination rates were statistically analyzed and found that the spore germination rates were low after 12 h, with the spore germination rates of strain BbOFJY and strain BbOFJYF being 37.29% and 32.79%, respectively. There was no significant difference in the spore germination rates between the two strains (P>0.05). Figure 7 C); at 16h, most of the spores had germinated, with the spore germination rate of strain BbOFJY being 90.32% and that of strain BbOFJY-F being 73.95%. The spore germination rate of strain BbOFJY was significantly higher than that of strain BbOFJYF (P<0.001) ( Figure 7 D). After 12 h and 16 h of culture, the spore germination rate of strain BbOFJY was higher than that of strain BbOFJYF.

[0089] 2.6.4 Determination of dry weight accumulation of bacteria

[0090] 2×10 of the two strains were added 7The spores were added to 20 mL SDY liquid medium and cultured at 26°C and 200 r / min for 1, 2, 3, 4, and 5 days. The dry weight of the bacteria was measured. Statistical analysis showed that the growth of strains BbOFJY and BbOFJYF was different. The growth of strain BbOFJYF was higher than that of strain BbOFJY on days 1-4, but the difference was not significant. On the 5th day, the growth of strain BbOFJY was higher than that of strain BbOFJYF, and the difference was still not significant. The dry weight of the two strains increased with the extension of the culture time, and the overall increase trend of strain BbOFJYF was slower ( Figure 8 ).

[0091] 2.6.5 Blastospore concentration

[0092] Add 5×10 7 The spores were added to 20 ml of SDY and TKI liquid medium and cultured at 26 ° C and 200 r / min. The concentration and morphology of spores and deep spores were recorded at 24h, 36h, 48h, 60h, 72h, 84h, 96h, 108h, and 120h. The concentration of spores of strains BbOFJY and strains BbOFJYF showed an overall upward trend, and the concentration of spores of strain BbOFJY was higher than that of strain BbOFJYF after 48h. The differences in the concentration of spores of strains were more significant at 72h, 84h and 120h, and the differences in the concentration of spores of strains were significant at 108h ( Fig. 9 ).

[0093] Example 3 Interspecies transmission of Beauveria bassiana virus and its effect on the virulence of Beauveria bassiana

[0094] 3.1 Interspecies transmission of Beauveria bassiana virus

[0095] The virus-containing strain BbOFJY and the engineered strain BbOFDH1-5 (CGMCC No. 15673) containing the glufosinate-resistant gene were activated and cultured on PDA medium at 26°C for 10 days. The conidia of the culture medium and the surface were scraped and the conidia of the two strains were prepared into 10 7 spores / ml spore suspension and mix thoroughly, immerse the live tussah silkworm pupae in the spore suspension for 10 seconds and then take it out, culture it at 26℃ for 7-10 days, and when the conidia of Beauveria bassiana grow on the surface of the tussah silkworm pupae, scrape 100 μl of conidia (concentration of 10 3 The culture medium (glufosinate concentration: 200 ng / μl) was spread on the surface of Czapek medium containing glufosinate resistance (glufosinate concentration: 200 ng / μl) and cultured for 15 days.

[0096] 3.2 Virus detection of infectious strains

[0097] The conidia produced on the surface of the medium containing glufosinate resistance in 3.1 were separated into single spores, and 20 single spores were randomly separated and inoculated on the sterilized PDA medium and cultured in the dark for 15 days. The grown colonies were cultured in the dark at 26°C on the medium again for 10 days, and subcultured twice continuously. Double-stranded RNA was extracted from the collected hyphae; the total RNA was reverse transcribed, and the obtained cDNA was used as a template to perform PCR amplification of the virus-specific sequence using the primers and amplification procedures in 2.1. RT-PCR was positive, indicating that the virus had been successfully introduced into the recipient strain BbOFDH1-5. One positive strain was randomly selected and marked as BbOFDH1-5-V for virulence determination.

[0098] 3.3 Detection of the toxicity of Beauveria bassiana to corn borer larvae

[0099] The strains BbOFDH1-5 and BbOFDH1-5-V inoculated in PDA medium were placed in a 26°C constant temperature incubator for 15 days, the bacterial cells were scraped off and dissolved in 0.05% Tween-80, and the mycelium was filtered out with sterile six-layer lens paper. The filtered spore solution was diluted to a concentration of 1.0×10 8 Pieces / mL.

[0100] Select the 2nd instar larvae of corn borer, and repeat 1 for every 20 larvae, and repeat 3 times for each concentration, with sterile 0.05% Tween-80 as the control. Immerse the insects head by head in 2ml spore suspension of Beauveria bassiana at different concentrations for 20s (the spore suspension can be replaced once for 20 larvae), and raise them normally in a 24-well feeding plate. The feeding conditions are a light cycle of 14L:10D, a temperature of 26°C, and a relative humidity of 75%. Observe the death situation every day, touch the insect body with a dissecting needle, and the insect body is dead if there is no reaction. Record the number of insect deaths every day, and record the effective number of larvae in the control group with a mortality rate of less than 20%. After the mortality rate of the tested insects in different treatments reaches more than 90%, establish a regression equation to calculate the lethal median time of different treatments.

[0101] 3.4 Results

[0102] 3.4.1 Virus detection of infectious strains

[0103] A total of 20 single spores were isolated, and 13 strains were initially screened to carry the virus. After two subcultures, double-stranded RNA extraction was performed, indicating that 8 strains still contained double-stranded RNA ( Fig.10 ) and verified by RT-PCR, indicating that the eight strains of viruses were genetically stable ( Fig.11 ).

[0104] 3.4.2 Toxicity assay

[0105] 1.0×10 8Under the treatment with spore concentration of 100 / mL, the mortality rate of larvae in the control group was 10%, the LT50 of larvae in the BbOFDH1-5 treatment group was 6.25 days, and the LT50 of larvae in the BbOFDH1-5-V treatment group was 5.21 days, indicating that the fungal polymeric double-stranded RNA virus BbPmV-4 can shorten the insecticidal time after being introduced into the recipient strain, that is, the virulence of the strain is improved.

Claims

1. A method for detecting whether Beauveria bassiana is a virus-free strain, wherein the deposit number of the Beauveria bassiana is CGMCC No. 22429, the virus-free means that the Beauveria bassiana is not infected with a polymycovirus, and the fungal virus that the Beauveria bassiana may carry is named Beauveria bassiana polymycovirus 4 (BbPmV-4); the method comprises the following steps: 1) isolating a single spore of the Beauveria bassiana, inoculating it on a PDA plate and placing it in a constant temperature incubator at 26° C. for dark culture for 5 days, cutting the mycelial tip and inoculating it on a new PDA plate for culture, and continuously cutting the mycelial tip and subculturing it for 5 generations; 2) extracting the dsRNA of the strain, and performing DNase I and S1 nuclease treatment, detection by 1% agarose gel electrophoresis, preliminary screening, to obtain dsRNA-free strains, wherein the original strain is used as a positive control; 3) RT-PCR detection of whether the strain is detoxified: total RNA is extracted from the preliminary screened strains, and N6 random primers are used as reverse transcription primers for amplification to obtain cDNA templates, and PCR amplification of viral retrograde sequences is performed using virus-specific primers, and agarose gel electrophoresis is used to detect whether dsRNA exists in the amplified products; in, In step 3), the reverse transcription primer is N6 random primer 10 pm / μL; The virus-specific primer pairs in the PCR in step 3) are: The PCR system is:

2. The method according to claim 1, in, The method for judging whether Beauveria bassiana is a virus-free strain is that after the PCR product is detected by agarose gel electrophoresis, the strains that amplify 333bp and 712bp by two pairs of primers are virus-containing strains; and the strains that are negative for the amplification products of the two pairs of primers are virus-free strains.

Citation Information

Patent Citations

  • Method for improving high-seepage property, oxidative stress resistance and toxicity of beauveria bassiana by utilizing genetic engineering

    CN103173467A

  • Method for improving beauveria bassiana conidiospore yield and virulence by use of genetic manipulation

    CN105274130A

  • Double-stranded RNA fungal virus of Chrysoviridae capable of improving mycelial growth rate of beauveria bassiana

    CN112322589A

  • Mycoinsecticide activity against grasshoppers produced by Beauveria bassiana

    US5939065A

  • Exploiting host molecules to augment the virulence of mycoinsecticides

    WO2013052536A2